ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SCLP Scancell Holdings Plc

9.60
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.60 9.40 9.80 9.60 9.60 9.60 114,837 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.44 89.07M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.60p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £89.07 million. Scancell has a price to earnings ratio (PE ratio) of -7.44.

Scancell Share Discussion Threads

Showing 60226 to 60250 of 65925 messages
Chat Pages: Latest  2421  2420  2419  2418  2417  2416  2415  2414  2413  2412  2411  2410  Older
DateSubjectAuthorDiscuss
15/3/2023
09:50
I said "can" - i.e. got quoted at 16.43 - I already more than enough!
nigelpm
15/3/2023
09:46
We need to remember what type of cancers and end stage patients that Moditope is actually working on, e.g.

HGSOC (high-grade serous ovarian cancer) is a very aggressive ovarian cancer. The cancer grows slowly in your fallopian tubes at first. But it then spreads rapidly once it reaches your ovaries. Unfortunately, most people with HGSOC have advanced (metastatic) ovarian cancer by the time they get a diagnosis. 5 year survival rates are 15 per cent.

marcusl2
15/3/2023
09:40
anyway .. have you bought your "plenty" ... Nigel
inanaco
15/3/2023
09:39
it's quite a bit when you hold 1.3m
inanaco
15/3/2023
09:38
Why quibble over 0.5p! Crazy.
nigelpm
15/3/2023
09:38
yes now you can, but not at 16p ... and 16.33

so how many have you just bought ?

inanaco
15/3/2023
09:32
I can buy plenty - change your broker Inanaco.
nigelpm
15/3/2023
09:24
"£700 at 16.33" -
Place your bets

the real lozan
15/3/2023
09:17
This could well be the event where Modi/Scancell hits the main news channels.
chillpill
15/3/2023
09:02
Lindy will have more data by April 18, 2023, 1:30 PM - 5:00 PM in Florida so that is 5.30 - 9pm BST UK.

Hopefully she can boast about additional partial responses by then. I am eager to see how Modi-1 plus CPI is doing.

When the data is good and they prove the method of operation then I would expect numerous offers for Moditope or the company.

April 14, 2023: Late-Breaking and Clinical Trials Abstract Texts Posted to Online Itinerary Planner and Meeting App (12 noon ET)

marcusl2
15/3/2023
08:45
Looks like the great reveal to the World is approaching.

Good news!

chillpill
15/3/2023
08:31
For those that have sold down ...... good luck buying back .... 27 mins to buy £1200 worth

Scancell presenting ... Modi1 is amazing

inanaco
15/3/2023
08:29
£700 at 16.33
inanaco
15/3/2023
08:18
got £500 at 16p .... but nothing else
inanaco
15/3/2023
08:16
trying to get a £1200 top up ......... unavailable
inanaco
15/3/2023
08:08
can't get a price
inanaco
15/3/2023
05:09
Yes great find by Bermuda ....... this is gold dust !!

and the great news .... its Next years, tax year .... ISA April 5th

inanaco
14/3/2023
22:22
Share price action here has been very frustrating (Notwithstanding the recent fall across markets generally). I do wonder if there's a concern over funding that'll be needed down the line.
nigelpm
14/3/2023
22:20
Burble



RE: AACR 2023Today 22:03
The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 12:00 p.m. U.S. ET on Friday, April 14, 2023, except those abstracts that are selected for inclusion in the official AACR press program. Abstracts that are featured in the official AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.

In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. Beginning in 2023, the Proceedings supplement will be published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) will be published on Friday, March 31, and Part 2 (clinical trials and late-breaking abstracts) will be published on Friday, April 14.

Revised Proceedings supplements containing the full text of embargoed abstracts as well as any late change will be published in Cancer Research approximately one month after the meeting.

marcusl2
14/3/2023
22:16
Bermudashorts


AACR 2023Today 21:38
Am delighted to see that Scancell have had an abstract accepted for presentation at the AACR Annual Meeting. This is one of the, if not the biggest scientific conferences in the world. The title of the abstract is:-

'Modi-1, anti-citrullinated neoepitope vaccine alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal and ovarian carcinoma: protocol for the ModiFY phase I/II basket clinical Trial'

It will be presented by Lindy Durrant on April 18, 2023, 1:30 PM - 5:00 PM

Good stuff - have been waiting since 2015 to see Scancell present at AACR/ASCO!

marcusl2
14/3/2023
21:38
So Pfizer have spent 43bn on a Company with treatments for Cancer after getting billions of needles in arms over the last couple of years. I am sure it is just a coincidence. Why aren't they interested in Scancell, have you ever thought that maybe Scancell's vaccines are too safe, not enough ADR's, no money in safe, effective cures. Scancell always the Bridesmaid never the Bride. I have been telling you for the last 18 months about the proliferation of Cancer and Doctors around the world reporting the aggressiveness and Patients going to straight to stage 4 and skipping stages 1,2 and 3.
panama7
14/3/2023
15:46
Synaffix and MacroGenics unveiled their antibody drug-conjugate (ADC) collaboration of four additional ADC programs, increasing the potential deal value by $2.2 billion



Pfizer's announcement Monday that it had bought cancer behemoth Seagen for $43 billion, in large part to capitalize on the company’s ADC prowess, served as another reminder of the attention the modality is getting.

Centered entirely around the antibody glycan, Synaffix has established a simple, rapidly deployable technology platform, enabling any company with an antibody to develop a proprietary, best-in-class ADC or bispecifics.

marcusl2
14/3/2023
10:01
" Beautiful to watch." -
Tarquin, No,I was talking about the European Red Kite
Unclear on the location (Thailand or Devon) to which you refer
The reason I refer to the wildlife is to highlight the benefits of a 'stressfree' lifestyle,,,as opposed to the obvious STRESSFUL drive which is present in most of the landan based thinking on these forums.

the real lozan
14/3/2023
08:25
Interesting that some of you are supporting the saving of SVB, a Bank where the Board awarded themselves 5m in bonuses last week and were busy selling shares to the tune of millions of dollars. Not surprised that some of you support this type of criminality after all some of you believe it is a positive to link Scancell to Pfizer the biggest criminal drug dealer on the planet, the Mexican cartels don't come close.
panama7
13/3/2023
23:56
Is that the large Brahminy kite with the white head ? In this area with many estuaries, some waterside restaurants feed them and then we see probably hundreds, circling and feeding off the river. Beautiful to watch.
torquayfan
Chat Pages: Latest  2421  2420  2419  2418  2417  2416  2415  2414  2413  2412  2411  2410  Older

Your Recent History

Delayed Upgrade Clock